|
| Press Releases |
|
 |
|
| Wednesday, September 16, 2015 |
|
|
Omnicare Trust PIERS to Accrue Contingent Interest |
| Omnicare, Inc. announced today that, for the quarterly interest period beginning September 15, 2015, its Trust Preferred Income Equity Redeemable Securities will, subject to the terms of the Trust PIERS, accrue contingent interest at a rate of approximately $0.15 per $50 stated liquidation amount of the Trust PIERS. more info >> |
|
| Wednesday, August 19, 2015 |
|
|
Omnicare Announces Conversion Rate Adjustments for Convertible Notes |
| Omnicare, Inc. announced today an adjustment to the conversion rate of its (i) 3.75% Convertible Senior Subordinated Notes due 2025, (ii) 3.50% Convertible Senior Subordinated Notes due 2044, (iii) 3.25% Convertible Senior Debentures due 2035 and (iv) 3.25% Convertible Senior Exchange Debentures due 2035. more info >> |
|
| Friday, July 24, 2015 |
|
|
Omnicare Reports Second-Quarter 2015 Financial Results |
| Omnicare, Inc. (NYSE: OCR) reported today financial results for its second quarter ended June 30, 2015. more info >> |
|
| Saturday, June 20, 2015 |
|
|
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest |
| Omnicare, Inc. (NYSE: OCR) (the "Company") announced today that, for the period from June 15, 2015 to September 14, 2015, its Series A and Series B Trust Preferred Income Equity Redeemable Securities will accrue contingent interest at a rate of 0.125% of the average trading price of the Trust PIERS for the five trading days ended June 11, 2015, in addition to the continued accrual of regular cash interest. more info >> |
|
| Friday, May 22, 2015 |
|
|
Omnicare Declares Quarterly Cash Dividend |
| Omnicare, Inc. (NYSE:OCR) (the "Company") today announced that its Board of Directors has approved a quarterly cash dividend of $0.22 per share on the Company's common stock, to be paid on June 30, 2015, to all stockholders of record on June 12, 2015. more info >> |
|
| Thursday, April 2, 2015 |
|
|
Omnicare to Report First-Quarter 2015 Financial Results and Hold Conference Call on Wednesday, April 29, 2015 |
| Omnicare, Inc. (NYSE:OCR) will release its financial results for the first quarter of fiscal 2015 before the market opens on Wednesday, April 29, 2015. more info >> |
|
| Saturday, March 28, 2015 |
|
|
Omnicare Announces Conversion Rate Adjustment for Convertible Notes; Series A and Series B Trust PIERS to Accrue Contingent Interest |
| Omnicare, Inc. (NYSE: OCR) (the "Company") announced today an adjustment to the conversion rate of its 3.75% Convertible Senior Subordinated Notes due 2025 (the "2025 Notes"). more info >> |
|
| Friday, March 6, 2015 |
|
|
Omnicare's Specialty Care Group Advanced Care Scripts (ACS) to Provide Specialty Pharmacy Services for Novartis' Farydak(R) |
| Advanced Care Scripts (ACS), a leading specialty pharmacy and clinical services platform of Omnicare Specialty Care Group (SCG), is proud to be part of the limited distribution network for the Novartis drug Farydak(R) (panobinostat). more info >> |
|
| Tuesday, March 3, 2015 |
|
|
Omnicare Specialty Care Group's ACS to Provide Specialty Pharmacy Services for Bayer's Nexavar(R) (sorafenib) and Stivarga(R) (regorafenib) |
| Advanced Care Scripts (ACS), a leading specialty pharmacy and clinical services platform of Omnicare's Specialty Care Group, has been chosen to dispense Bayer's Nexavar(R) (sorafenib) and Stivarga(R) (regorafenib) as part of their limited distribution networks. more info >> |
|
| Thursday, February 26, 2015 |
|
|
Omnicare Reports Fourth-Quarter and Full-Year 2014 Financial Results; Company Provides Full-Year 2015 Guidance |
| Omnicare, Inc. (NYSE:OCR) reported today financial results for its fourth quarter and full year ended December 31, 2014. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
SAKENOVA: 28-Year-Old Master Brewer Pioneers AI-Driven Sake Revolution, Achieving 40% Cost Reduction While Winning International Gold Medals
Dec 15, 2025 0:00 JST
|
|
|
GMG Unveils Graphene Aluminium-Ion Battery That Fully Charges in 6 Minutes
Dec 15, 2025 21:09 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China
Dec 15, 2025 21:00: JST
|
|
|
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China
Dec 15, 2025 21:00 HKT/SGT
|
|
|
NEC Provides Vehicle Management Equipment for Autonomous Driving at Tokyo International Airport
Dec 15, 2025 19:41 JST
|
|
|
希迪智駕招股進行中：構築智能駕駛產業化底座 多場景落地打開成長空間
Dec 15, 2025 18:06 HKT/SGT
|
|
|
希迪智驾招股进行中：构筑智能驾驶产业化底座 多场景落地打开成长空间
Dec 15, 2025 18:06 HKT/SGT
|
|
|
NEC and AEROTHAI Elevate Air Traffic Safety with Advanced Time Sync Solutions from Adtran Oscilloquartz
Dec 15, 2025 19:04 JST
|
|
|
Everest Medicines Unveils 2030 Strategy as Directors and Substantial Shareholder Buy Over HKD 38 Million of Shares
Dec 15, 2025 17:59: JST
|
|
|
Everest Medicines Unveils 2030 Strategy as Directors and Substantial Shareholder Buy Over HKD 38 Million of Shares
Dec 15, 2025 16:59 HKT/SGT
|
|
|
雲頂新耀發佈2030戰略規劃 管理層及主要股東增持超3800萬港元股份
Dec 15, 2025 16:59 HKT/SGT
|
|
|
云顶新耀发布2030战略规划 管理层及主要股东增持超3800万港元股份
Dec 15, 2025 16:59 HKT/SGT
|
|
|
Indonesia's KAI Launches Farmer-Trader Train, Expands Facial Recognition Tech Ahead of 2025/2026 Holiday Travel Surge
Dec 15, 2025 13:00 HKT/SGT
|
|
|
国资护航+技术壁垒+优质保荐 华芢生物（02396.HK）PDGF管线直指18A赛道确定性价值
Dec 15, 2025 11:05 HKT/SGT
|
|
|
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Dec 15, 2025 09:51 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
